絞り込み

16643

広告

「denosumab」の検索結果

2760件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Letter to the Editor: Bone health and denosumab treatment in autoimmune liver diseases: a possible involvement of physical activity.

Reply to Letter to the Editor (HEP-19-1638).

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.

Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysis.

Real World Experience of Denosumab Treatment in the Belfast Osteoporosis Service.

Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis.

Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab.

Combination therapies in the treatment of osteoporosis.

Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.

Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.

[Radium-223 for the treatment of metastatic castration-resistant prostate cancer (mCRPC) : The androgen receptor-independent active agent in the therapeutic sequence].

Giant cell tumor of bone: Unusual features of a rare tumor.

From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights.

Denosumab Prevents Early Periprosthetic Bone Loss after Uncemented Total Hip Arthroplasty: Results from a Randomized Placebo-Controlled Clinical Trial.

HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia.

Bone modifying agents for patients with bone metastases from breast cancer managed in routine practice setting: Treatment patterns and outcome.

Patient-Level Modeling Approach Using Discrete-Event Simulation: A Cost-Effectiveness Study of Current Treatment Guidelines for Women with Postmenopausal Osteoporosis.

Bone-Targeted Agents in Breast Cancer: Do We Now Have All the Answers?

Reossification and Prognosis following Radiotherapy with/without Surgery for Spinal Solitary Plasmacytoma of the Bone: A Retrospective Study of 39 Patients.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります